Peter Devilee
Peter Devilee
Leiden University Medical Center
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Identification of the breast cancer susceptibility gene BRCA2
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, ...
Nature 378 (6559), 789-792, 1995
Pathology and genetics of tumours of the breast and female genital organs
JN Eble, FA Tavassoli, P Devilee
Iarc, 2003
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ...
The American Journal of Human Genetics 62 (3), 676-689, 1998
Mutations in the p53 gene occur in diverse human tumour types
JM Nigro, SJ Baker, AC Preisinger, JM Jessup, R Hosteller, K Cleary, ...
Nature 342 (6250), 705-708, 1989
Genome-wide association study identifies novel breast cancer susceptibility loci
DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ...
Nature 447 (7148), 1087-1093, 2007
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
R Wooster, SL Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, ...
Science 265 (5181), 2088-2090, 1994
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
BE Baysal, RE Ferrell, JE Willett-Brozick, EC Lawrence, D Myssiorek, ...
Science 287 (5454), 848-851, 2000
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
CHEK2-Breast Cancer Consortium
Nature genetics 31 (1), 55, 2002
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ...
Nature genetics 45 (4), 353-361, 2013
WHO classification of tumors. Tumors of the breast and female genital organs
FA Tavassoli
Lyon IRAC, 100-103, 2003
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype
SR Lakhani, JS Reis-Filho, L Fulford, F Penault-Llorca, M van der Vijver, ...
Clinical cancer research 11 (14), 5175-5180, 2005
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations
SR Lakhani, J Jacquemier, JP Sloane, BA Gusterson, TJ Anderson, ...
Journal of the National Cancer Institute 90 (15), 1138-1145, 1998
SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma
HX Hao, O Khalimonchuk, M Schraders, N Dephoure, JP Bayley, H Kunst, ...
Science 325 (5944), 1139-1142, 2009
World Health Organization classification of tumors
FA Tavassoli
Pathology and genetics of tumors of the breast and female genital organs 97, 2003
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies
XR Yang, J Chang-Claude, EL Goode, FJ Couch, H Nevanlinna, RL Milne, ...
Journal of the National Cancer Institute 103 (3), 250-263, 2011
Gene-panel sequencing and the prediction of breast-cancer risk
DF Easton, PDP Pharoah, AC Antoniou, M Tischkowitz, SV Tavtigian, ...
New England Journal of Medicine 372 (23), 2243-2257, 2015
Association analysis identifies 65 new breast cancer risk loci
K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ...
Nature 551 (7678), 92, 2017
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
LC Verhoog, CTM Brekelmans, C Seynaeve, LMC Van den Bosch, ...
The Lancet 351 (9099), 316-321, 1998
In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors
AHN Hopman, FCS Ramaekers, AK Raap, JLM Beck, P Devilee, ...
Histochemistry 89 (4), 307-316, 1988
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23. 2
S Ahmed, G Thomas, M Ghoussaini, CS Healey, MK Humphreys, R Platte, ...
Nature genetics 41 (5), 585-590, 2009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20